This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Healthcare
Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.
Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum
-
29 Mar 2016 | Global | Market Research
Wearable Technologies in Clinical and Consumer Health, Forecast to 2020
Potential for Effective Management of Chronic Diseases to Create $30 Billion Market Opportunity
This research service analyzes the global market for wearable technologies in clinical and consumer health. It discusses in detail how industry convergence and technological innovations are transitioning wearables from simple consumer devices to actionable healthcare applications—specifically in managing targeted chronic diseases such as diabetes...
$4,950.00 -
12 Feb 2016 | Global | Market Research
Vital Signs - Impact of Strategic Acquisitions on Life Sciences Market, 2016
Portfolio Expansions Follow Acquisitions by Panasonic Healthcare Holdings Co.,Thermo Fisher Scientific and Abbott Laboratories
This Vital Signs issues discusses Panasonic Healthcare's completed acquisition of Bayer's Diabetes Care Unit, Thermo Fisher Scientific's acquisition of Affymetrix, several moves in the single cell-genomics market by Bio-Rad, Illumina, Qiagen, and 10x Genomics, and Abbott's acquisition of Alere.
$450.00 -
04 Feb 2016 | Global | Market Research
Vital Signs - Spiraling US Drug Costs, Wearable Healthcare Technologies and the Zika Virus, An Analysis
Urgent Remedial Action Required as Nearly 1/4th US Prescription Drug Users Find it Difficult to Afford their Prescriptions
This issue of Vital Signs discusses why the US pays more than other countries for drugs, the inside story on wearable electronics, the spreading Zika virus, and soaring US drug costs.
$450.00 -
03 Feb 2016 | Global | Market Research
Growing Burden of Lifestyle Diseases in Emerging Countries
The Healthcare and Life Sciences Growth Trajectory Beyond BRICS
While low and middle income group countries are typically characterized by a high burden of communicable diseases, the trend appears to be changing. By 2030, NCDs are expected to account for nearly 55% of the disease burden of these country groups. A growing middle aged population increases the risk of NCDs in the low and middle income country grou...
$1,500.00 -
05 Jan 2016 | Global | Market Research
Vital Signs - Advances in Cancer Treatment, Clampdown on Specialty Pharmacies and Strategy Revamp for Sequencing Provider, An Analysis
Liquid Biopsy Test for Prostate Cancer and Non-small Cell Lung Cancer Treatment Show Promise
This issue of Vital Signs discusses MDxHealth's launch of the SelectMDx Liquid Biopsy Test in Europe, the FDA's approval of a new treatment for non-small cell lung cancer with EGFR mutations, the clamp down on specialty pharmacies by US drug benefit managers, and BGI's strategy redirection for Complete Genomics.
$450.00
